Laquinimod

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Laquinimod

Postby bromley » Fri Jun 20, 2008 1:04 am

User avatar
bromley
Family Elder
 
Posts: 1887
Joined: Fri Sep 10, 2004 3:00 pm

Advertisement

Postby gwa » Fri Jun 20, 2008 5:45 am

The main thrust of the med is to reduce lesion loan. Lesion load has been shown to have no bearing on progression of the disease or symptoms of the disease, so I am not sure what will be gained with this med.

gwa
User avatar
gwa
Family Elder
 
Posts: 846
Joined: Thu Dec 01, 2005 4:00 pm

Postby daverestonvirginia » Sat Jun 21, 2008 8:27 am

"Lesion load has been shown to have no bearing on progression of the disease or symptoms of the disease"

Is this really the case? I do not understand how having less lesions would not be a very good thing? Are not lessions the disease at work? I understand how lesions and symptoms might not be directly related, but I would think many lesions would not be good.
User avatar
daverestonvirginia
Family Elder
 
Posts: 182
Joined: Mon Apr 09, 2007 3:00 pm
Location: Reston, Virginia

Lesion load comment

Postby lyndacarol » Sat Jun 21, 2008 12:24 pm

Dave, GWA is spot on about the lesion load! In fact, I begin to question the neurological connection at the onset of this disease at all. My first MRIs, EMG testing, and Evoked Potentials were all normal when my MS symptoms first began; it was months later that the MRI showed anything.

We must always remember the "individuality" aspect--my MS may not be like anyone else's.
User avatar
lyndacarol
Family Elder
 
Posts: 2317
Joined: Thu Dec 22, 2005 4:00 pm


Return to Drug Pipeline

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service